Drug companies settled opioid lawsuits for billions of dollars this year, and some filed for bankruptcy, but the litigation is far from over. Several closely watched appeals are coming up, and, for some defendants, the fight has just begun.

Pharmaceutical manufacturers, drug distributors and pharmacies settled during, or just before, trials this year against states, cities and counties that sued over the opioid crisis. Distributors AmerisourceBergen, Cardinal Health and McKesson, along with Johnson & Johnson’s Janssen Pharmaceuticals, moved forward on their $26 billion global settlement, and Teva Pharmaceutical Industries and Allergan reached multistate deals worth billions of dollars. Endo International, another manufacturer, filed for bankruptcy protection, potentially resolving thousands of opioid lawsuits for $450 million.

Paul Geller of Robbins Geller Rudman & Dowd. Courtesy photo

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]